Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a Comprehensive Profiling Program: Impact on Precision Medicine Oncology.
Patricia Martin-RomanoLaura MezquitaAntoine HollebecqueLudovic LacroixEtienne RouleauAnas GazzahRastilav BahledaDavid PlanchardAndrea VargaCapucine BaldiniSophie Postel-VinayLuc FribouletYohann LoriotLoic VerlingueArthur GeraudMaud Ngo CamusClaudio NicotraJean Charles SoriaFabrice AndréBenjamin BesseChristophe MassardAntoine ItalianoPublished in: JCO precision oncology (2022)
Implementation of ESCAT classification for clinical decision making by Molecular Tumor Board is feasible and useful to better tailor therapies in patients with cancer.